Cross-Cultural Validation of the RECAP of Atopic Eczema Question-naire in a Swedish Population
| العنوان: | Cross-Cultural Validation of the RECAP of Atopic Eczema Question-naire in a Swedish Population |
|---|---|
| المؤلفون: | Sigurdardottir, Gunnthorunn, Alsterholm, Mikael, Andersson, Chris D., Bradley, Maria, Sandström Falk, MariHelen, Johansson, Emma K., Lundqvist, Maria, Sonesson, Andreas, Svensson, Åke, Theodosiou, Grigorios, Vrang, Sophie, von Kobyletzki, Laura B., 1971 |
| المصدر: | Acta Dermato-Venereologica. 104 |
| مصطلحات موضوعية: | atopic dermatitis, eczema, patient-reported out- come measure, validation study |
| الوصف: | A Swedish translation of the patient-reported outcome measure for assessing long-term control of atopic dermatitis, Recap of atopic eczema (RECAP), has not been validated. Cross-cultural translation and multi-centre validation of the translated RECAP questionnaire were therefore performed. Disease severity was assessed using the validated Investigator Global Assessment Scale for atopic dermatitis (vIGA-ADTM). The Swedish RECAP was completed by 208 individuals aged 16 years or older with a median age of 36 years (interquartile range [IQR] 27-48). The participants considered the questionnaire suitable for assessing eczema control. The median RECAP score (range 0-28) was 12 (IQR 5-19). The mean and median vIGA-ADTM scores (range 0-4) were 2 (standard deviation [SD] 2) and 3 (IQR 2-4), respectively. A correlation between RECAP and the vIGA-ADTM was observed (p < 0.001). There was no significant change in scores for participants who answered the questionnaire twice within 14 days. Over time, improved or worsened eczema, as evaluat-ed by vIGA-ADTM, affected RECAP scores significantly (p < 0.001). The study suggests that RECAP can assess AD control in a Swedish clinical setting and shows -acceptable reliability. |
| وصف الملف: | |
| URL الوصول: | https://urn.kb.se/resolve?urn=urn:nbn:se:oru:diva-114366 https://doi.org/10.2340/actadv.v104.38889 |
| قاعدة البيانات: | SwePub |
| تدمد: | 00015555 16512057 |
|---|---|
| DOI: | 10.2340/actadv.v104.38889 |